ViGeneron

ViGeneron was founded in 2017, with its headquarters located in Munich. It is a biotechnology startup spun off from Ludwig Maximilian University of Munich (LMU). The company leverages its two technology platforms (vgAAV vector platform and REVeRT split AAV platform) to address currently unmet ophthalmic medical needs through internal gene therapy programs targeting specific retinal diseases.